Related Experiment Video
Updated: May 19, 2026
Metabolic Characterization of Polarized M1 and M2 Bone Marrow-derived Macrophages Using Real-time Extracellular Flux Analysis
Published on: November 28, 2015
ApoE Lipidation State Directs Immunometabolic Reprogramming of Human Microglia
Introduction:
ApoE4 is the strongest genetic risk factor for Alzheimer's disease (AD). Emerging evidence suggests that ApoE4 increases AD risk by disrupting microglial metabolism and function. However, whether ApoE lipidation state contributes to microglial dysfunction remains poorly understood.
Methods:
Human microglia were treated with lipid-free or lipid-bound ApoE3 or ApoE4. Label-free live-cell holotomography and global proteomics were used to assess isoform- and lipidation-specific effects on lipid droplet dynamics, mitochondrial morphology, and microglial phenotype.
Results:
ApoE4 treatment resulted in fewer but enlarged lipid droplets and increased mitochondrial fragmentation compared to ApoE3, effects that were enhanced by lipid-bound ApoE4. Proteomic analyses revealed a strong type I interferon response in cells exposed to lipid-free ApoE, which was exacerbated by lipid-free ApoE4.
Discussion:
These findings indicate that lipid-bound ApoE4 drives metabolic reprogramming, whereas lipid-free ApoE4 promotes inflammatory signaling, identifying ApoE lipidation as a critical modifier of ApoE4-associated AD risk.
Insights
Apolipoprotein E4 (ApoE4) increases Alzheimer's disease risk. Lipid-bound ApoE4 alters microglial metabolism, while lipid-free ApoE4 triggers inflammation, revealing lipidation's role in ApoE4's effects.
Area of Science:
- Neuroscience
- Genetics
- Cell Biology
Background:
- Apolipoprotein E4 (ApoE4) is a major genetic risk factor for Alzheimer's disease (AD).
- ApoE4's impact on microglial metabolism and function is implicated in AD pathogenesis.
- The role of ApoE lipidation status in ApoE4-induced microglial dysfunction is unclear.
Purpose of the Study:
- To investigate the effects of ApoE isoform and lipidation state on human microglial metabolism and phenotype.
- To determine how lipid-bound versus lipid-free ApoE4 influences microglial function.
Main Methods:
- Human microglia were treated with lipid-free or lipid-bound ApoE3 or ApoE4.
- Label-free live-cell holotomography assessed lipid droplet dynamics and mitochondrial morphology.
- Global proteomics analyzed microglial phenotype and signaling pathways.
Main Results:
- ApoE4 treatment led to enlarged lipid droplets and mitochondrial fragmentation compared to ApoE3.
- Lipid-bound ApoE4 exacerbated these effects.
- Lipid-free ApoE, particularly ApoE4, induced a strong type I interferon response.
Conclusions:
- Lipid-bound ApoE4 drives metabolic changes in microglia.
- Lipid-free ApoE4 promotes inflammatory signaling.
- ApoE lipidation is a critical factor modulating ApoE4's contribution to Alzheimer's disease risk.
